-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...
More »SEARCH RESULT
From January 2015, life-saving drugs to show govt-fixed rates in bold red -Sushmi Dey
-The Times of India NEW DELHI: All life saving drugs from January 2015 will come with a bold red strip on their packs highlighting price as fixed by the government and also specify if they are under price control. Signaling a New Year gift for consumers, the government is set to make it mandatory for regulated drugs to print on their packs 'DPCO Scheduled Drug' in black ink on a bold...
More »Mala Fide Decision on Drug Prices
-Economic and Political Weekly The decision to reduce the powers of the drug pricing body goes against the interest of public health. The decision of the Government of India to withdraw the power of the National Pharmaceutical Pricing Authority (NPPA) to set price controls on drugs that are not on the National List of Essential Medicines (NLEM) raises questions on the Narendra Modi regime's commitment to people's welfare. One must ask if...
More »Drug price tug of war: people vs others -S Srinivasan
-The Hindu Business Line The media have got it wrong on price control reversal Recently, there has been a flutter in various media channels and newspapers as to how the Modi Government has reversed certain drug price control measures announced in July 2014. As a result, we are told, prices of these drugs would increase much more than pre-July levels. This was supposed to be a sequel to Modi's visit to the...
More »Government curbs power of regulator to cap HIV, cancer drug prices -Rupali Mukherjee
-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...
More »